Approaching the community about screening children for a multicentre malaria vaccine trial

Approaching the community about screening children for a multicentre malaria vaccine trial

Pokaži ostale verzije (1)

Community sensitisation, as a component of community engagement, plays an important role in strengthening the ethics of community-based trials in developing countries and is fundamental to trial success. However, few researchers have shared their community sensitisation strategies and experiences. W...

Bibliografski detalji
Glavni autori:	Lang, T, Gould, J, von Seidlein, L, Lusingu, J, Mshamu, S, Ismael, S, Liheluka, E, Kamuya, D, Mwachiro, D, Olotu, A, Njuguna, P, Bejon, P, Marsh, V, Molyneux, C
Format:	Journal article
Jezik:	English
Izdano:	2012

Slični predmeti

Approaching the community about screening children for a multicentre malaria vaccine trial.
od: Lang, T, i dr.
Izdano: (2012)

Feedback of Research Findings for Vaccine Trials: Experiences from Two Malaria Vaccine Trials Involving Healthy Children on the Kenyan Coast
od: Gikonyo, C, i dr.
Izdano: (2013)

Feedback of research findings for vaccine trials: experiences from two malaria vaccine trials involving healthy children on the Kenyan Coast.
od: Gikonyo, C, i dr.
Izdano: (2013)

Complex realities: community engagement for a paediatric randomized controlled malaria vaccine trial in Kilifi, Kenya.
od: Angwenyi, V, i dr.
Izdano: (2014)

Complex realities: Community engagement for a paediatric randomized controlled malaria vaccine trial in Kilifi, Kenya
od: Angwenyi, V, i dr.
Izdano: (2014)

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: experiences and perceptions of study participants in a malaria Challenge study in Kenya
od: Njue, M, i dr.
Izdano: (2018)

Working with Community Health Workers as 'volunteers' in a vaccine trial: practical and ethical experiences and implications.
od: Angwenyi, V, i dr.
Izdano: (2013)

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".
od: Bejon, P, i dr.
Izdano: (2009)

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya [version 2; referees: 2 approved]
od: Maureen Njue, i dr.
Izdano: (2018-10-01)

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya [version 1; referees: 2 approved]
od: Maureen Njue, i dr.
Izdano: (2018-04-01)

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan-based malaria infection study
od: Jao, I, i dr.
Izdano: (2020)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
od: Bejon, P, i dr.
Izdano: (2008)

What we learned about voluntariness and consent: incorporating "background situations" and understanding into analyses.
od: Kamuya, D, i dr.
Izdano: (2011)

What we learned about voluntariness and consent: Incorporating "background situations" and understanding into analyses
od: Kamuya, D, i dr.
Izdano: (2011)

Malaria vaccines: past, present and future.
od: von Seidlein, L, i dr.
Izdano: (2013)

Malaria vaccines: Past, present and future
od: Von Seidlein, L, i dr.
Izdano: (2013)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
od: Bejon, P, i dr.
Izdano: (2008)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
od: Lusingu, J, i dr.
Izdano: (2010)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
od: Bejon, P, i dr.
Izdano: (2011)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
od: Bejon, P, i dr.
Izdano: (2009)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
od: Olotu, A, i dr.
Izdano: (2013)

Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
od: Olotu, A, i dr.
Izdano: (2012)

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data
od: Bejon, P, i dr.
Izdano: (2013)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
od: Olotu, A, i dr.
Izdano: (2010)

'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya.
od: Marsh, V, i dr.
Izdano: (2011)

Community members employed on research projects face crucial, often under-recognized, ethical dilemmas.
od: Molyneux, S, i dr.
Izdano: (2010)

Community members employed on research projects face crucial, often under-recognized, ethical dilemmas
od: Molyneux, S, i dr.
Izdano: (2010)

Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites.
od: Bejon, P, i dr.
Izdano: (2011)

Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study
od: Chi, PC, i dr.
Izdano: (2022)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
od: Olotu, A, i dr.
Izdano: (2016)

Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt
od: Noni Mumba, i dr.
Izdano: (2022-04-01)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
od: Bejon, P, i dr.
Izdano: (2013)

Undertaking community engagement for a controlled human malaria infection study in Kenya: approaches and lessons learnt
od: Mumba, N, i dr.
Izdano: (2022)

Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
od: Ally Olotu, i dr.
Izdano: (2012-01-01)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
od: Ndungu, F, i dr.
Izdano: (2019)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
od: John Lusingu, i dr.
Izdano: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
od: John Lusingu, i dr.
Izdano: (2010-11-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
od: John Lusingu, i dr.
Izdano: (2010-01-01)

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast
od: Kangoye, D, i dr.
Izdano: (2016)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
od: Horowitz, A, i dr.
Izdano: (2012)